Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

DR AGARWALS EYE HOSPITAL LTD.

NSE : NABSE : 526783ISIN CODE : INE934C01018Industry : Hospital & Healthcare ServicesHouse : Private

BSE5235.7062.35 (+1.21 %)

PREV CLOSE ( ) 5173.35

OPEN PRICE ( ) 5479.95

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 1769

TODAY'S LOW / HIGH ( )5200.00 5650.00

52 WK LOW / HIGH ( ) 35007300

NSE

This Company is not listed in NSE

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 22-04 1994

Management Info

Amar Agarwal - Chairman Amar Agarwal - Managing Director

Registered Office

Address 3rd Floor, Buhari Towers, No.4, Moores Road,Off. Greams Road,Near Asan Memorial School,
Chennai,
Tamil Nadu-600006

Phone 044-43787777 / 78

Email info@dragarwal.com

Website www.dragarwal.com

Registrars Details

Integrated Registrary Management Services Pvt Ltd.-(Formerly Integrated Enterprises (India) Ltd)

II Floor , Kences Towers,No 1 Ramakrishna Street,North Usman Road, T Nagar,Chennai

Listing : BSE

NEWS

27Oct Dr. Agarwal’s Eye Hospital informs abo
In furtherance to letter dated October 22, 2025, Dr. Agarwal’s Eye Hospi..

25Aug Preferential Issue of Shares
Preferential Issue of shares & Inter alia, to consider and approve:- (1..

19Mar Dr Agarwals Eye Hospital commences ope
Dr Agarwals Eye Hospital has commenced operation of a new branch located..

30Sep Dr. Agarwal’s Eye Hospital informs abo
As per the SEBI (Prohibition of Insider Trading) Regulations, 2015 and t..

28Sep Dr.Agarwals Eye Hospital informs about
Dr.Agarwals Eye Hospital has informed that the Exchange has received Dis..

Financials

Rs. in Millions

	QTR Sep 25	ANNUAL 25
Net Profit	193.2	546.5
Gross Profit	257.2	707
Operating Profit	407.6	1235.9
Net Sales	1177.2	3971.5

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Dr. Lal Pathlabs (BSE) 3137.05 (1.56%)	M.Cap ( in Cr)26280.80
Thyrocare Tech. (BSE) 1396.60 (3.54%)	M.Cap ( in Cr)7409.51
Indraprastha Medical (BSE) 603.90 (2.22%)	M.Cap ( in Cr)5536.13
Yatharth Hospital (BSE) 796.75 (1.14%)	M.Cap ( in Cr)7677.03
Kaya (BSE) 446.15 (1.99%)	M.Cap ( in Cr)677.60

Shareholding Pattern

	PROMOTERS	72.67%
	NON-INSTITUTION	23.23%
	MUTUAL FUNDS/UTI	0.18%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
WOC Pharma and Heal...	0.62

Risk Disclosures on Derivatives

Smart Quotes

DR AGARWALS EYE HOSPITAL LTD.